Navigation Links
Prince Charles lends support to Alternative Medicine

In an open show of support to Alternative Medicine, Britain's Prince Charles has urged the government to allocate 10 million pounds ($14.21 million) to fund a five-year research program into the effects of alternative medicine. The world is now sitting up and taking notice of holistic medicine and Prince Charles’s support to fund research in this field has come as a shot in the arm for these crusaders of integrated medicine.

Charles, a long-standing advocate of alternative medicine, had held a 90-minute meeting with Health Secretary Alan Milburn over funding for the Foundation for Integrated Medicine, founded by the prince in 1996.

Most of these studies into alternative medicine suffer from paucity of funds and this appeal by the Prince has given added impetus to the research. "It is critical that government funding is made available for this initiative," Michael Fox, the foundation's chief executive, was quoted as saying.

The scope of Ayurveda, Homeopathy, Siddha Medicine, Acupuncture and other forms of alternative medicine has increased tremendously over the past few years that doctors advice Holistic Medicine which is an umbrella of all forms of medicine for the betterment of the patient. But as long as the patient is benefited who’s complaining?

"Prince Charles has been at the forefront of the campaign for integrated medicine. It will be good news if more money is now forthcoming," a spokesman for Charles was quoted as saying
'"/>




Page: 1

Related medicine news :

1. When A Prince Chose To Help Indian Couple
2. Prince Of Wales Is Alarmed By The Obesity Wave In Britain
3. Prince Harry Launches AIDS Charity In Memory Of Princess Diana
4. Japanese Princess Kiko May Deliver Heir Through Cesarean Section
5. Miracle Boy Prince Declared Fit by Medical Team
6. A Princely Assistance to the Nepal Heritage
7. Princess Kiko Offers To Donate Cord Blood For Leukemia Transplantation
8. Evidence supporting H.pylori eradication
9. Further support for use of statins in Alzheimer’s disease
10. Toxin injections support stroke associated spasticity
11. Vitamin E supports Female Hearts
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... 2017 , ... Donna Parker, L. Ac. reads all sorts of books on ... to be very practical. She wanted to write a guide/workbook that would give readers ... It prompted her in writing “ A Clear Path to a Vibrant Life : ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue ... Oral Reconstruction Foundation will present its annual Global Symposium at the Fontainebleau Hotel ...
(Date:4/23/2017)... ... April 23, 2017 , ... "An event Horizon is ... the process rendered in my Art and Music. These are created as Metaphysical Transformations ... the boundary of mystery culminate to the ultimate singularity.", -- Karen Salicath Jamali , ...
(Date:4/22/2017)... (PRWEB) , ... April 22, 2017 , ... ... to his role as Vice President of Sales and Business Development at OAKWORKS, ... GPO/IDN business partner engagements, business development, and strategic planning for the company. ...
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary ... that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright ... people involved in violence in the United States. The study, Trends in ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... NeuroVive Pharmaceutical AB (Nasdaq Stockholm: ... preclinical results demonstrating anti-fibrotic effects with NV556, ... (NASH), in an additional well-validated experimental NASH ... previously shown similar anti-fibrotic effects in the ... present novel data demonstrating anti-fibrotic effects of ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology: